Efficacy of RiboDIET® and RiboMIX SC in mild cognitive impairment

Mild Cognitive Impairment (MCI) is an early, potentially reversible stage of cognitive decline characterized by reduced cognitive performance while daily functioning remains intact. Nutritional strategies for MCI aim to preserve cognitive function and support compensatory mechanisms.
In this context, RiboDIET® (250 mg/day) and RiboMIX SC (350 mg/day), yeast extracts rich in bioavailable nucleotides, have shown significant cognitive benefits.
In a randomized, controlled clinical trial, 6-month supplementation led to measurable improvements in cognitive performance, as assessed with the validated Montreal Cognitive Assessment and Mini-Mental State Examination, supporting targeted nucleotide supplementation as a promising nutritional approach for cognitive health in MCI.